We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Noninvasive Fetal Sex Determination Performed in Just 8 to 10 Weeks of Pregnancy

By LabMedica International staff writers
Posted on 04 Jan 2010
A simple blood test may soon become available that reveals the sex of an unborn baby.

This is the conclusion of researchers, from the University of Amsterdam (The Netherlands), who published their study in the January 2010 issue of the journal Obstetrics and Gynecology. The researchers' goal was to determine the diagnostic accuracy of noninvasive fetal sex determination in maternal plasma. More...
Real-time polymerase chain reaction (PCR) was performed for the SRY gene and multicopy DYS14 marker sequence. Between 2003 and 2009, they tested women who were between 8 and 10 weeks pregnant, examining DNA from their blood samples to predict the sex of the babies in 186 pregnancies. They predicted 105 boys and 81 girls. They were correct every time.

This appears to be good news for parents. Determining the sex of an unborn baby can lead to early detection of specific disorders. Genetic diseases such as hemophilia and Duchenne muscular dystrophy are carried by the X chromosome that usually occurs in males.

Critics, however, warn this is similar to opening Pandora's box as fetal testing evolves. Parents might not always appreciate what they discover. However, critics may be too late to stop the technology from progressing.

The researchers, however, concluded in their study that noninvasive fetal sex determination in maternal plasma is highly effective and clinically applicable.

Related Links:

University of Amsterdam




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.